The purpose of this study is to understand if a new oral medication (pill) can be used to treat depression in people who have not felt relief from other anti-depression medications.
You will be asked to come in for a screening visit to find out if you are eligible to participate. If you are able to participate, you will take a study medication daily for 4 weeks, and you will be asked to come to the clinic each week for a visit. After you finish the medication, you will be asked to come in for two additional follow-up visits 1 and 2 weeks after you finish the medication. During the clinic visits, you will be asked questions about how you are feeling. We will also have a blood draw at each visit and have your heart activity measured by an ECG.
$100 per visit completed, up to $800
Clinical and Translational Research Center (CTRC)
Burnett-Womack Building (UNC-Chapel Hill)
160 Dental Cir, Chapel Hill, NC 27514, USA
Samantha Meltzer-Brody
Psychiatry - General
Clinical or Medical
Interventional
Behavior
Mental and Emotional Health
Women's Health
Men's Health
24-0253
Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.
Questions?
